Heat shock proteins and p53 play a critical role in K+ channel-mediated tumor cell proliferation and apoptosis

Apoptosis

Volumn 12, Issue 10, 2007, Pages 1837-1846

  Han, Xiaobing ^a,b   Wang, Fang ^c   Yao, Weixing ^c   Xing, Hui ^a   Weng, Danhui ^a   Song, Xiaohong ^a   Chen, Gang ^a   Xi, Ling ^a   Zhu, Tao ^a   Zhou, Jianfeng ^a   Xu, Gang ^a   Wang, Shixuan ^a   Meng, Li ^a   Iadecola, Costantino ^d   Wang, Gang ^d   Ma, Ding ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Cancer proliferation; Cell cycle; Patch clamp; Potassium channels; Voltage gated

Indexed keywords

4 AMINOPYRIDINE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; CALCIUM ACTIVATED POTASSIUM CHANNEL; GLIBENCLAMIDE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN 90ALPHA; HEAT SHOCK PROTEIN 90BETA; IBERIOTOXIN; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; PROTEIN BAX; PROTEIN P21; PROTEIN P53; TETRANDRINE; TETRYLAMMONIUM; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONDUCTANCE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; PATCH CLAMP; POTASSIUM CURRENT; PRIORITY JOURNAL; TUMOR CELL; WESTERN BLOTTING; WHOLE CELL;

4-AMINOPYRIDINE; ALKALOIDS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BENZYLISOQUINOLINES; CALCIUM CHANNEL BLOCKERS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA FRAGMENTATION; DNA-BINDING PROTEINS; GLYBURIDE; HEAT-SHOCK PROTEINS; HUMANS; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; NEOPLASMS; ONCOGENE PROTEINS, VIRAL; PATCH-CLAMP TECHNIQUES; PEPTIDES; POTASSIUM CHANNEL BLOCKERS; TETRAETHYLAMMONIUM; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34848902026     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-007-0101-9     Document Type: Article

References (40)

1. Wonderlin WF, Strobl JS (1996) Potassium channels, proliferation and G1 progression. J Membr Biol 154:91-107
2. + channels in regulating tumour cell proliferation and apoptosis. Pflugers Arch 448:274-286
3. Kunzelmann K (2005) Ion channels and cancer. J Membr Biol 205:159-173
4. Pardo LA, Contreras-Jurado C, Zientkowska M, Alves F, Stuhmer W (2005) Role of voltage-gated potassium channels in cancer. J Membr Biol 205:115-124
5. Lang F, Foller M, Lang KS et al (2005) Ion channels in cell proliferation and apoptotic cell death. J Membr Biol 205:147-157
6. + channel activation. J Membr Biol 172:113-120
7. Plummer H, Yu Q, Cakir Y, Schuller H (2004) Expression of inwardly rectifying potassium channels (GIRKs) and beta-adrenergic regulation of breast cancer cell lines. BMC Cancer 4:93-103
8. Liu SI, Chi CW, Lui WY et al (1998) Correlation of hepatocyte growth factor-induced proliferation and calcium-activated potassium current in human gastric cancer cells. Biochim Biophys Acta 1368:256-266
9. Liu X, Chang Y, Reinhart PH, Sontheimer H, Chang Y (2002) Cloning and characterization of glioma BK, a novel BK channel isoform highly expressed in human glioma cells. J Neurosci 22:1840-1849
10. + currents by 2-mercaptophenyl-1,4-naphthoquinone in pituitary GH3 cells: contribution to its antiproliferative effect. Life Sci 70:1185-1203
11. + channels inhibit human pancreatic cancer cell growth in vitro. Mol Pharmacol 65:630-638
12. Malhi H, Irani AN, Rajvanshi P et al (2000) KATP channels regulate mitogenically induced proliferation in primary rat hepatocytes and human liver cell lines. Implications for liver growth control and potential therapeutic targeting J Biol Chem 275:26050-26057
13. + channels identification in human breast carcinoma cells: involvement in cell proliferation. Biochem Biophys Res Commun 278:272-277
14. Pardo LA, del Camino D, Sanchez A et al (1999) Oncogenic potential of EAG K(+) channels. Embo J 18:5540-7
15. + channel, a regulator of tumor cell apoptosis and proliferation. Cancer Res 62:4843-4848
16. Crociani O, Guasti L, Balzi M et al (2003) Cell cycle-dependent expression of HERG1 and HERG1B isoforms in tumor cells. J Biol Chem 278:2947-2955
17. Latorre R, Miller C (1983) Conduction and selectivity in potassium channels. J Membr Biol 71:11-30
18. + current in pituitary GH3 cells. Chin J Physiol 44:161-167
19. + channel modulators on human prostate cancer cell proliferation. Eur J Pharmacol 471:157-164
20. + channels in breast cancer cells: association with cell cycle progression. Am J Physiol Cell Physiol 287:C125-C134
21. Ransom CB, Sontheimer H (2001) BK channels in human glioma cells. J Neurophysiol 85:790-803
22. Ransom CB, Liu X, Sontheimer H (2002) BK channels in human glioma cells have enhanced calcium sensitivity. Glia 38:281-291
23. Weaver AK, Liu X, Sontheimer H (2004) Role for calcium-activated potassium channels (BK) in growth control of human malignant glioma cells. J Neurosci Res 78:224-234
24. DeFilippis RA, Goodwin EC, Wu L, DiMaio D (2003) Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence, and apoptosis in HeLa cervical carcinoma cells. J Virol 77:1551-1563
25. + channels in breast cancer cells. Biochem Biophys Res Commun 316:244-251
26. Akar F, Uydes-Dogan BS, Buharalioglu CK et al (1999) Protective effect of cromakalim and diazoxide, and proulcerogenic effect of glibenclamide on indomethacin-induced gastric injury. Eur J Pharmacol 374:461-470
27. Chrabi A, Horisberger JD (1999) Stimulation of epithelial sodium channel activity by the sulfonylurea glibenclamide. J Pharmacol Exp Ther 290:341-347
28. 2+ current in isolated nerve terminals of the rat neurohypophysis. Pflugers Arch 421:558-565
29. + channels. Life Sci 56:295-306
30. Wang G, Lemos JR, Iadecola C (2004) Herbal alkaloid tetrandrine: fron an ion channel blocker to inhibitor of tumor proliferation. Trends Pharmacol Sci 25:120-123
31. Chen YJ (2002) Potential role of tetrandrine in cancer therapy. Acta Pharmacol Sin 23:1102-1106
32. Jin S, Levine AJ (2001) The p53 functional circuit. J Cell Sci 114:4139-4140
33. Gomez-Lazaro M, Fernandez-Gomez FJ, Jordan J (2004) p53: 25 years understanding the mechanism of genome protection. J Physiol Biochem 60:287-307
34. Zamzami N, Kroemer G (2005) p53 in apoptosis control: an introduction. Biochem Biophys Res Commun 331:685-687
35. O'Connor PM, Jackman J, Bae I et al (1997) Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents. Cancer Res 57:4285-4300
36. Franco-Gou R, Rosello-Catafau J, Casillas-Ramirez A, Massip-Salcedo M, Rimola A, Calvo N, Bartrons R, Peralta C (2006) how ischaemic preconditioning protects small liver grafts. J Pathol 208:62-73
37. Shinohara T, Takahashi N, Ooie T, Ichinose M, Hara M, Yonemochi H, Saikawa T, Yoshimatsu H (2004) Estrogen inhibits hyperthermia-induced expression of heat-shock protein 72 and cardioprotection against ischemia/reperfusion injury in female rat heart. Mol Cell Cardiol 37:1053-1061
38. Kiang JG, Gist ID, Tsokos GC (2000) Regulation of heat shock protein 72 kDa and 90 kDa in human breast cancer MDA-MB-231 cells. Mol Cell Biochem 204:169-178
39. Neckers L, Ivy SP (2003) Heat shock protein 90. Curr Opin Oncol 15:419-424
40. Zylicz M, King FW, Wawrzynow A (2001) Hsp70 interactions with the p53 tumour suppressor protein. Embo J 20:4634-4638